申请人:Theracos, Inc.
公开号:US20140031300A1
公开(公告)日:2014-01-30
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.
提供了具有抑制钠依赖性葡萄糖共转运体SGLT的化合物。本发明还提供了制备这些化合物的制药组合物、方法、合成中间体以及使用这些化合物的方法,独立地或与其他治疗剂联合使用,用于治疗受SGLT抑制影响的疾病和病症。